ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).
Research output: Contribution to journal › Article › peer-review
Authors
Colleges, School and Institutes
External organisations
- Cardiff University
- Velindre Cancer Centre
Details
Original language | English |
---|---|
Pages (from-to) | 4101-410 |
Number of pages | 9 |
Journal | Journal of Clinical Oncology |
Publication status | Published - 2020 |